Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 283

1.

Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.

Cheng CP, Sheu MJ, Sytwu HK, Chang DM.

Rheumatology (Oxford). 2013 Apr;52(4):609-22. doi: 10.1093/rheumatology/kes343. Epub 2012 Dec 7.

PMID:
23221330
[PubMed - indexed for MEDLINE]
2.

Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.

Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.

J Bone Miner Res. 2005 Apr;20(4):653-62. Epub 2004 Dec 6.

PMID:
15765185
[PubMed - indexed for MEDLINE]
3.

Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Lee JW, Iwahashi A, Hasegawa S, Yonezawa T, Jeon WB, Cha BY, Nagai K, Woo JT.

J Nat Med. 2012 Jan;66(1):8-16. doi: 10.1007/s11418-011-0537-7. Epub 2011 Jun 9.

PMID:
21656335
[PubMed - indexed for MEDLINE]
4.

Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.

Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.

J Cell Physiol. 2009 Dec;221(3):618-28. doi: 10.1002/jcp.21892.

PMID:
19653230
[PubMed - indexed for MEDLINE]
5.

Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.

Gong W, Dou H, Liu X, Sun L, Hou Y.

Clin Exp Pharmacol Physiol. 2012 Oct;39(10):886-93. doi: 10.1111/j.1440-1681.2012.12006.x.

PMID:
23013134
[PubMed - indexed for MEDLINE]
6.
7.

Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.

Hasegawa H, Kido S, Tomomura M, Fujimoto K, Ohi M, Kiyomura M, Kanegae H, Inaba A, Sakagami H, Tomomura A.

J Biol Chem. 2010 Aug 13;285(33):25448-57. doi: 10.1074/jbc.M109.068742. Epub 2010 Jun 14.

PMID:
20547767
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.

Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45.

PMID:
15752732
[PubMed - indexed for MEDLINE]
9.

Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.

Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.

Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.

PMID:
23928189
[PubMed - indexed for MEDLINE]
10.

Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.

Ko SY.

Arch Oral Biol. 2012 Dec;57(12):1623-32. doi: 10.1016/j.archoralbio.2012.06.012. Epub 2012 Jul 12.

PMID:
22795564
[PubMed - indexed for MEDLINE]
11.

Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.

Kim WS, Kim HJ, Lee ZH, Lee Y, Kim HH.

Exp Cell Res. 2013 Feb 15;319(4):436-46. doi: 10.1016/j.yexcr.2012.12.004. Epub 2012 Dec 12.

PMID:
23246654
[PubMed - indexed for MEDLINE]
12.

Plectranthus amboinicus attenuates inflammatory bone erosion in mice with collagen-induced arthritis by downregulation of RANKL-induced NFATc1 expression.

Hsu YC, Cheng CP, Chang DM.

J Rheumatol. 2011 Sep;38(9):1844-57. doi: 10.3899/jrheum.101223. Epub 2011 Jul 1.

PMID:
21724708
[PubMed - indexed for MEDLINE]
13.

Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.

Ang ES, Pavlos NJ, Chai LY, Qi M, Cheng TS, Steer JH, Joyce DA, Zheng MH, Xu J.

J Cell Physiol. 2009 Dec;221(3):642-9. doi: 10.1002/jcp.21898.

PMID:
19681045
[PubMed - indexed for MEDLINE]
14.

Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.

Tsuji-Naito K.

Bioorg Med Chem. 2008 Oct 15;16(20):9176-83. doi: 10.1016/j.bmc.2008.09.036. Epub 2008 Sep 14.

PMID:
18823786
[PubMed - indexed for MEDLINE]
15.

Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells.

Nagasawa T, Arai M, Togari A.

Arch Oral Biol. 2011 Sep;56(9):924-31. doi: 10.1016/j.archoralbio.2011.02.002. Epub 2011 Mar 5.

PMID:
21377143
[PubMed - indexed for MEDLINE]
16.

Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).

Odkhuu E, Koide N, Haque A, Tsolmongyn B, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T.

Immunol Lett. 2012 Feb 29;142(1-2):34-40. doi: 10.1016/j.imlet.2011.12.001. Epub 2011 Dec 13.

PMID:
22193059
[PubMed - indexed for MEDLINE]
17.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.

PMID:
16059638
[PubMed - indexed for MEDLINE]
18.

Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.

Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.

Bone. 2007 Oct;41(4):592-602. Epub 2007 Jun 13.

PMID:
17627913
[PubMed - indexed for MEDLINE]
19.

Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.

Franco GC, Kajiya M, Nakanishi T, Ohta K, Rosalen PL, Groppo FC, Ernst CW, Boyesen JL, Bartlett JD, Stashenko P, Taubman MA, Kawai T.

Exp Cell Res. 2011 Jun 10;317(10):1454-64. doi: 10.1016/j.yexcr.2011.03.014. Epub 2011 Mar 21.

PMID:
21420951
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk